Israël - hébreu - Ministry of Health

neopharm cure (2005) ltd - midazolam as hydrochloride - תמיסה לחלל הפה - midazolam as hydrochloride 2.5 mg - midazolam

Israël - hébreu - Ministry of Health

neopharm cure (2005) ltd - midazolam as hydrochloride - תמיסה לחלל הפה - midazolam as hydrochloride 5 mg - midazolam

Israël - hébreu - Ministry of Health

neopharm cure (2005) ltd - midazolam as hydrochloride - תמיסה לחלל הפה - midazolam as hydrochloride 7.5 mg - midazolam

Israël - hébreu - Ministry of Health

neopharm (israel) 1996 ltd - zoledronic acid as monohydrate - תרכיז להכנת תמיסה לאינפוזיה - zoledronic acid as monohydrate 4 mg - zoledronic acid

Israël - hébreu - Ministry of Health

neopharm (israel)1996 ltd - adalimumab - תמיסה להזרקה - adalimumab 50 mg/ml - adalimumab

Israël - hébreu - Ministry of Health

neopharm (israel)1996 ltd - berotralstat as dihydrochloride - קפסולות - berotralstat as dihydrochloride 110 mg - berotralstat

Israël - hébreu - Ministry of Health

neopharm (israel) 1996 ltd - berotralstat as dihydrochloride - קפסולות - berotralstat as dihydrochloride 150 mg - berotralstat

Israël - hébreu - Ministry of Health

neopharm (israel) 1996 ltd - maralixibat chloride - תמיסה (פומי) - maralixibat chloride 10 mg/ml - maralixibat chloride

Israël - hébreu - Ministry of Health

neopharm (israel)1996 ltd - icosapent ethyl - קפסולות רכות - icosapent ethyl 998 mg

Israël - hébreu - Ministry of Health

neopharm ltd - ranolazine 1000 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.